Anakinra as First-line Monotherapy Wins in sJIA (CME/CE)

(MedPage Today) -- Study reports " highly efficacious strategy to induce and sustain inactive disease and to prevent disease- and glucocorticoid-related damage "
Source: MedPage Today Pediatrics - Category: Pediatrics Source Type: news
More News: Pediatrics | Study